quinagolide and Migraine-Disorders

quinagolide has been researched along with Migraine-Disorders* in 2 studies

Other Studies

2 other study(ies) available for quinagolide and Migraine-Disorders

ArticleYear
The clinical characteristics of headache in patients with pituitary tumours.
    Brain : a journal of neurology, 2005, Volume: 128, Issue:Pt 8

    The clinical characteristics of 84 patients with pituitary tumour who had troublesome headache were investigated. The patients presented with chronic (46%) and episodic (30%) migraine, short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT; 5%), cluster headache (4%), hemicrania continua (1%) and primary stabbing headache (27%). It was not possible to classify the headache according to International Headache Society diagnostic criteria in six cases (7%). Cavernous sinus invasion was present in the minority of presentations (21%), but was present in two of three patients with cluster headache. SUNCT-like headache was only seen in patients with acromegaly and prolactinoma. Hypophysectomy improved headache in 49% and exacerbated headache in 15% of cases. Somatostatin analogues improved acromegaly-associated headache in 64% of cases, although rebound headache was described in three patients. Dopamine agonists improved headache in 25% and exacerbated headache in 21% of cases. In certain cases, severe exacerbations in headache were observed with dopamine agonists. Headache appears to be a significant problem in pituitary disease and is associated with a range of headache phenotypes. The presenting phenotype is likely to be governed by a combination of factors, including tumour activity, relationship to the cavernous sinus and patient predisposition to headache. A proposed modification of the current classification of pituitary-associated headache is given.

    Topics: Adenoma; Adult; Aminoquinolines; Antineoplastic Agents, Hormonal; Bromocriptine; Cabergoline; Disability Evaluation; Dopamine Agonists; Ergolines; Female; Headache; Humans; Male; Migraine Disorders; Octreotide; Peptides, Cyclic; Pituitary Neoplasms; Severity of Illness Index; Somatostatin; Time Factors

2005
Benign intracranial hypertension associated with the withdrawal of a non-ergot dopamine agonist.
    Journal of neurology, neurosurgery, and psychiatry, 1994, Volume: 57, Issue:3

    The cases are reported of two patients who developed benign intracranial hypertension after the withdrawal of the novel non-ergot derived dopamine agonist CV 205 502 (quinagolide).

    Topics: Adult; Aminoquinolines; Cerebrovascular Circulation; Dopamine Agents; Female; Humans; Hyperprolactinemia; Migraine Disorders; Pseudotumor Cerebri; Substance Withdrawal Syndrome

1994